177 related articles for article (PubMed ID: 17515895)
1. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
Medyouf H; Alcalde H; Berthier C; Guillemin MC; dos Santos NR; Janin A; Decaudin D; de Thé H; Ghysdael J
Nat Med; 2007 Jun; 13(6):736-41. PubMed ID: 17515895
[TBL] [Abstract][Full Text] [Related]
2. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
3. Linking calcineurin activity to leukemogenesis.
Müller MR; Rao A
Nat Med; 2007 Jun; 13(6):669-71. PubMed ID: 17554330
[No Abstract] [Full Text] [Related]
4. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas.
Fruman DA; Mather PE; Burakoff SJ; Bierer BE
Eur J Immunol; 1992 Oct; 22(10):2513-7. PubMed ID: 1382988
[TBL] [Abstract][Full Text] [Related]
5. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
[TBL] [Abstract][Full Text] [Related]
6. TRESK channel as a potential target to treat T-cell mediated immune dysfunction.
Han J; Kang D
Biochem Biophys Res Commun; 2009 Dec; 390(4):1102-5. PubMed ID: 19852929
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.
Hernández-Espinosa D; Morton AJ
Brain Res Bull; 2006 May; 69(6):669-79. PubMed ID: 16716837
[TBL] [Abstract][Full Text] [Related]
8. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia.
Gachet S; Genescà E; Passaro D; Irigoyen M; Alcalde H; Clémenson C; Poglio S; Pflumio F; Janin A; Lasgi C; Dodier S; Soyer M; Duménil G; Ghysdael J
Leukemia; 2013 Dec; 27(12):2289-300. PubMed ID: 23689515
[TBL] [Abstract][Full Text] [Related]
10. Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
Cecchinato V; Erba E; Basile A; Scarpati B; Fazi C; Brando B; Comi P; Chiaramonte R
Leuk Res; 2008 May; 32(5):791-7. PubMed ID: 17964649
[TBL] [Abstract][Full Text] [Related]
11. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells.
Wang H; Zhou CL; Lei H; Wei Q
J Biochem; 2010 Feb; 147(2):185-90. PubMed ID: 19880376
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
Du MR; Zhou WH; Dong L; Zhu XY; He YY; Yang JY; Li DJ
Biol Reprod; 2008 Jun; 78(6):1102-10. PubMed ID: 18322274
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
[TBL] [Abstract][Full Text] [Related]
16. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain.
Luo J; Ma J; Yu DY; Bu F; Zhang W; Tu LH; Wei Q
Brain Res Bull; 2008 Jul; 76(5):464-8. PubMed ID: 18534252
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators.
Nejat S; Zaki A; Hirsch GM; Lee TD
Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin enhances acetylcholinesterase mRNA stability during C2-C12 muscle cell differentiation.
Luo ZD; Wang Y; Werlen G; Camp S; Chien KR; Taylor P
Mol Pharmacol; 1999 Nov; 56(5):886-94. PubMed ID: 10531391
[TBL] [Abstract][Full Text] [Related]
19. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
[TBL] [Abstract][Full Text] [Related]
20. Induction of cerebellar long-term depression requires activation of calcineurin in Purkinje cells.
Fujiwara A; Kakizawa S; Iino M
Neuropharmacology; 2007 Jun; 52(8):1663-70. PubMed ID: 17485101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
